Clinical Trials in Levallois-Perret, Hauts-de-Seine
2 recruiting
Showing 1–2 of 2 trials
Recruiting
Phase 3
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Triple-Negative Breast Cancer
Merck Sharp & Dohme LLC1,530 enrolled288 locationsNCT06393374
Recruiting
First Observatory of Precocious Puberty.
Puberty, Precocious
Hospices Civils de Lyon3,360 enrolled25 locationsNCT06263868